Quick Takeaways
- Nantahala Capital Management, LLC filed SCHEDULE 13D/A for EVOKE PHARMA, INC. Common Stock, par value $0.0001 per share (EVOK).
- Disclosed ownership: 16%.
- Date of event: 03 Feb 2025.
Nantahala Capital Management, LLC - 03 Feb 2025 SCHEDULE 13D/A Report for EVOKE PHARMA, INC. Common Stock, par value $0.0001 per share (EVOK)
- Filing Manager
- Nantahala Capital Management, LLC
- Reporting Manager
- Nantahala Capital Management, LLC
- Symbol
- EVOK
- Shares outstanding
- 1,592,489 shares
- Disclosed Ownership
- 254,639 shares
- Ownership
- 16%
- Form type
- SCHEDULE 13D/A
- Filing time
- 03 Feb 2025, 16:47:07 UTC
- Date of event
- 03 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Nantahala Capital Management, LLC disclosed 16% ownership in EVOKE PHARMA, INC. Common Stock, par value $0.0001 per share (EVOK) on 03 Feb 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 03 Feb 2025, 16:47.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 16% | 254,639 | 0 | 254,639 | /s/ Taki Vasilakis | Taki Vasilakis/Chief Compliance Officer | 0001472322 |
| Wilmot B. Harkey | 16% | 254,639 | 0 | 254,639 | /s/ Wilmot B. Harkey | Wilmot B. Harkey/Manager | |
| Daniel Mack | 16% | 254,639 | 0 | 254,639 | /s/ Daniel Mack | Daniel Mack/Manager |